TAPAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tapazole, and what generic alternatives are available?
Tapazole is a drug marketed by King Pharms and King Pharms Llc and is included in two NDAs.
The generic ingredient in TAPAZOLE is methimazole. There are three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tapazole
A generic version of TAPAZOLE was approved as methimazole by MYLAN on March 29th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAPAZOLE?
- What are the global sales for TAPAZOLE?
- What is Average Wholesale Price for TAPAZOLE?
Summary for TAPAZOLE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 174 |
| Clinical Trials: | 3 |
| Patent Applications: | 2,721 |
| Drug Prices: | Drug price information for TAPAZOLE |
| DailyMed Link: | TAPAZOLE at DailyMed |
Recent Clinical Trials for TAPAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Case Comprehensive Cancer Center | Phase 2 |
| Emory University | Early Phase 1 |
| University of Pisa | N/A |
US Patents and Regulatory Information for TAPAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | TAPAZOLE | methimazole | TABLET;ORAL | 007517-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms Llc | TAPAZOLE | methimazole | TABLET;ORAL | 040320-002 | Mar 31, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms | TAPAZOLE | methimazole | TABLET;ORAL | 007517-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
